| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |